Reduced-dose Alemtuzumab for Kidney Transplant Rejection

Clinical trial NCT06100965 · UNKNOWN

Trial details

NCT number: NCT06100965
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Kidney Transplant Rejection

Start date: 2023-12-01
Primary completion: 2025-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.